These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2652516)

  • 1. Use of rabbit globulin anti-CD4+ lymphocyte clone derived from a rejected kidney in the prevention of rejection in kidney transplantation: a pilot study.
    Hourmant M; Babinet F; Cantarovich D; Latour M; Carcagne J; Vié H; Bonneville M; Moreau JF; Carosella E; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1587-8. PubMed ID: 2652516
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y; Ohshima S; Fujita T; Kinukawa T; Matsuura O; Hirabayashi S; Takeuchi N
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
    McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
    N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract]   [Full Text] [Related]  

  • 6. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
    Schilling M; Schleibner S; Abendroth D; Illner WD; Schneeberger H; Land W
    Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
    [No Abstract]   [Full Text] [Related]  

  • 7. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe kidney graft rejection in combined kidney and pancreas transplantation.
    Hedman L; Frisk B; Brynger H; Frödin L; Tufveson G; Wahlberg J
    Transplant Proc; 1987 Oct; 19(5):3911-2. PubMed ID: 3313961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM; Mendes NF; Ramos OL; Sabbaga E
    Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042
    [No Abstract]   [Full Text] [Related]  

  • 10. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
    Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
    [No Abstract]   [Full Text] [Related]  

  • 11. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract]   [Full Text] [Related]  

  • 12. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood eosinophilia and renal allograft rejection.
    Frenken LA; Leunissen KM; van den Berg-Loonen PM; Kootstra G; van Hooff JP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1584-5. PubMed ID: 3079028
    [No Abstract]   [Full Text] [Related]  

  • 16. Minnesota experience with 81 pancreas transplants since 1978.
    Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved results of renal transplantation in diabetic nephropathy.
    Wilczek H; Gunnarsson R; Lundgren G; Ost L
    Transplant Proc; 1984 Jun; 16(3):623-7. PubMed ID: 6375029
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.